The Use of Derivatives of α-MSH for Targeting to Melanomas In Vivo

Malignant melanoma in man is noted for early metastasis and resistance to most conventional therapies. These properties make the necessity for targeted agents particularly urgent. An accurate imaging agent would assist the surgeon and the efficient targeting of cytotoxics would enable their therapeutic ratios to be significantly improved.